Bio Green Med Solution (UXI1) Stock Overview

Engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. More details

UXI1 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Earnings have grown 5.7% per year over the past 5 years

Risk Analysis

Shareholders have been substantially diluted in the past year

Makes less than USD$1m in revenue ($81K)

Shares are highly illiquid

Has less than 1 year of cash runway

+ 1 more risk

UXI1 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW432,867 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

432,867 investors already sharing narratives

View all narratives

Bio Green Med Solution, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bio Green Med Solution
Historical stock prices
Current Share Price	US$1.48
52 Week High	US$14.64
52 Week Low	US$1.11
Beta	-0.48
1 Month Change	0%
3 Month Change	0%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-47.69%

Recent updates

Shareholder Returns

	UXI1	DE Biotechs	DE Market
7D	0%	4.9%	0.3%
1Y	n/a	0.8%	5.0%

Return vs Industry: Insufficient data to determine how UXI1 performed against the German Biotechs industry.

Return vs Market: Insufficient data to determine how UXI1 performed against the German Market.

Price Volatility

Is UXI1's price volatile compared to industry and market?
UXI1 volatility
UXI1 Average Weekly Movement	n/a
Biotechs Industry Average Movement	5.4%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	12.4%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: UXI1's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine UXI1's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1996	n/a	Doris Wong	bgmsglobal.com

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It also researches and develops pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022.

Bio Green Med Solution, Inc. Fundamentals Summary

How do Bio Green Med Solution's earnings and revenue compare to its market cap?
UXI1 fundamental statistics
Market cap	€4.01m
Earnings (TTM)	-€6.01m
Revenue (TTM)	€69.77k

57.5x

P/S Ratio

-0.7x

P/E Ratio

Is UXI1 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
UXI1 income statement (TTM)
Revenue	US$81.00k
Cost of Revenue	US$1.74m
Gross Profit	-US$1.66m
Other Expenses	US$5.32m
Earnings	-US$6.97m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-1.42
Gross Margin	-2,048.15%
Net Profit Margin	-8,609.88%
Debt/Equity Ratio	0%

How did UXI1 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/03/08 08:05
End of Day Share Price	2025/12/09 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bio Green Med Solution, Inc. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kimberly Lee	Brean Capital Historical (Janney Montgomery)
Michael King	Citizens JMP Securities, LLC
Andrew Fein	H.C. Wainwright & Co.

Bio Green Med Solution, Inc.MUN:UXI1 Stock Report